Russell Steven Jon
Chief Medical Officer
Russell Steven Jon has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Russell Steven Jon is listed as Chief Medical Officer at Beta Bionics, Inc. Inside the rolling window, Russell Steven Jon reported no open-market purchases and 4 open-market sales totaling $177K in BBNX. The largest disclosed transaction in the window is a sale of 4,221 BBNX shares on Sep 2, 2026, worth $81K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$177K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Russell Steven Jon made?
Russell Steven Jon has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Russell Steven Jon trade?
Russell Steven Jon has filed SEC Form 4 disclosures for 1 company, including BBNX.
When was Russell Steven Jon's most recent SEC Form 4 filing?
Russell Steven Jon's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Russell Steven Jon's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Russell Steven Jon is listed as Chief Medical Officer.
What is Russell Steven Jon's total buy and sell value in the current window?
Inside the rolling retention window, Russell Steven Jon bought $0 and sold $177K based on SEC Form 4 filings.
What was Russell Steven Jon's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,221 BBNX shares on 2026-09-02, worth $81K, per SEC Form 4 filings.